It’s Tuesday at the 2017 JP Morgan Healthcare conference in San Francisco.
Each day of #JPM17 we’re doing a rolling blog post which we’re updating throughout the day with commentary and insights on the company presentations we’re covering.
While we’re not giving a blow-by-blow account, many companies have the slides readily available, we will be commenting on noteworthy news, and what we learn about pharma/biotech corporate strategy going into 2017.
For those of you who like to catch up with the final summary of each day’s highlights, you can read our post around Day 1 here (Link).
Yesterday we also published a thought leader interview we did with Dr Stephan Grupp, Director of the Cancer Immunotherapy Program at CHOP about some of the latest CAR T cell data and emerging issues we heard at #ASH16 last month (Link). Do check it out!
Subscribers can login to read more
It’s Day 1 of the 2017 JP Morgan Healthcare Conference in San Francisco…
Despite the travel challenges associated with the cold weather hitting much of the United States, many have made [or are in the process of making] the “pilgrimage” to hear leading pharma and emerging biotech companies lay out their strategy and goals for the coming year.
Every company that presents at #JPM17 has made their New Year’s resolutions… and like the ones we make personally, some will work out, while others will fall short.
In light of the success of our rolling blog from last years’ JPM conference (link to #JPM16 coverage), we’ve decided to repeat the concept again this year. Throughout the day (schedule permitting) we’ll be updating the post with commentary around news that catches our attention.
If you want to follow along yourself and listen to the company presentations, here’s the link to the JPM17 webcasts and conference agenda (link).
As an aside, in our coverage we will be using JPM followed by the last two digits of the year of the meeting i.e. #JPM17, last year it was #JPM16. This is how the “BioTwitter” community commonly refers to the meeting, and we will be continuing that tradition, notwithstanding the fact that JP Morgan have announced the “official” Twitter hashtag is awkward and long winded #JPMHC35.
Subscribers can login to read more.